Home - Products - Others - Other Targets - 7-methoxy-8-hydroxy-4-methylcoumarin

7-methoxy-8-hydroxy-4-methylcoumarin

CAS No. 22084-94-2

7-methoxy-8-hydroxy-4-methylcoumarin( —— )

Catalog No. M21448 CAS No. 22084-94-2

7-Methoxy-4-methyl-coumarin-8-ol (compound 31) is a compound isolated from sour orange (Citrus aurantium).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 64 In Stock
5MG 67 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-methoxy-8-hydroxy-4-methylcoumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Methoxy-4-methyl-coumarin-8-ol (compound 31) is a compound isolated from sour orange (Citrus aurantium).
  • Description
    7-Methoxy-4-methyl-coumarin-8-ol (compound 31) is a compound isolated from sour orange (Citrus aurantium).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22084-94-2
  • Formula Weight
    206.19
  • Molecular Formula
    C11H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (484.99 mM)
  • SMILES
    CC(c(c(O1)c2O)ccc2OC)=CC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 5'-O-(4,4'-Dimethoxy...

    5'-O-(4,4'-Dimethoxytrityl)-2'-deoxyuridine is a competitive dUTP nucleotidohydrolase (dUTPase) inhibitor(Ki > 1 mM) in E. coli.

  • β-Endorphin, equine ...

    β-Endorphin, equine (TFA) is an endogenous opioid peptide, which binds at high affinity to both μ/δ opioid receptors.

  • Luxdegalutamide

    Luxdegalutamide (ARV-766) is a novel, potent, and orally bioavailable proteolytic targeting chimera (PROTAC) protein degrader that degrades not only wild-type AR but also clinically relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.